Basic Information
Matrix Biomed is a biopharmaceutical company dedicated to improving drug development through genomic profiling. Gene-based therapies target both the dysfunction of one or more genes and the interactions between genes. Matrix Biomed redefines disease models by constructing extensive gene regulatory networks and gene co-expression networks, which can identify abnormal gene expression in diseases relative to healthy states. By redefining human diseases within these networks, Matrix Biomed has developed therapeutic agents that show the ability to restore abnormally expressed genes to a healthy state. By establishing genes involved in disease mechanisms, Matrix Biomed accelerates the efficiency of discovering and identifying novel treatment methods, effectively treating the disease without unnoticed negative side effects.
Matrix Biomed, Inc.
California,United States of America
15~50 people
--
info@matrixbiomed.com

